PRURITIS
Clinical trials for PRURITIS explained in plain language.
Never miss a new study
Get alerted when new PRURITIS trials appear
Sign up with your email to follow new studies for PRURITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could tame stubborn hives when antihistamines fail
Disease control CompletedThis phase 2 trial tested an oral drug called povorcitinib in 136 adults with chronic spontaneous urticaria (hives and itching lasting months) that standard antihistamines couldn't control. Participants took either povorcitinib or a placebo for 12 weeks to see if the drug reduced…
Matched conditions: PRURITIS
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug KPL-716 aims to stop the itch of prurigo nodularis
Symptom relief CompletedThis phase 2 trial tested an investigational drug called KPL-716 (vixarelimab) in 240 adults with prurigo nodularis, a skin condition causing intense itching and hard nodules. The study compared the drug to a placebo to see if it could reduce itch severity over several weeks. The…
Matched conditions: PRURITIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC